5McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist(IL-1 Ra) gene is associated with ankylosing spondylitis.Rheumatology( Oxford), 2001, 40 ( 12 ) : 1359 - 1364.
6Van der Paardt M, Crusius J B, Garcia-Gonzalez M A,Baudoin P, Kostense P J, Alizadeh B Z, Dijkmans B A,Pena A S, van der Horst Bruinsma I E. Intedeukin-lbeta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology ( Oxford), 2002,41 (12) :1419 - 1423.
7Maksymowych W P, Reeve J P, Reveille J D, Akey J M,Buenviaje H, O' Brien L, Peloso P M, Thomson G T, JinL, Russell A S. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum,2003,48(7) :2011 -2018.
8Timms A E, Crane A M, Sims A M, Cordell H J, Bradbury L A,Abbott A,Coyne M R, Beynon O, Herzberg I, Duff GW,Calin A,Cardon L R,Wordsworth B P, Brown M A. The Interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet, 2004, 75(4) :587 -595.
9Brown M A, Edwards S, Hoyle E, Campbell S, Laval S,Daly A K, Pile K D, Calin A, Ebringer A, Weeks D E,Wordsworth B P. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet, 2000, 9(11 ) :1563 - 1566.
10Jaakkola E, Crane A M, Laiho K, Herzberg It Sims A M tBradbury L t Calin A, Brophy St Kauppi M, Kaarela K,Wordsworth B P , Tuomilehto J, Brown M A. The effect of transforming growth factor-beta1 gene polymorphisms in ankylosing spondylitis. Rheumatology(Oxford) , 2004,43(1) :32 -38.
